Attention Deficit Hyperactivity Disorder (ADHD) News and Research RSS Feed - Attention Deficit Hyperactivity Disorder (ADHD) News and Research Twitter

Attention deficit-hyperactivity disorder (ADHD) is a neurobehavioral disorder that affects 3-5 percent of all American children. It interferes with a person's ability to stay on a task and to exercise age-appropriate inhibition (cognitive alone or both cognitive and behavioral). Some of the warning signs of ADHD include failure to listen to instructions, inability to organize oneself and school work, fidgeting with hands and feet, talking too much, leaving projects, chores and homework unfinished, and having trouble paying attention to and responding to details. There are several types of ADHD: a predominantly inattentive subtype, a predominantly hyperactive-impulsive subtype, and a combined subtype. ADHD is usually diagnosed in childhood, although the condition can continue into the adult years.

Study examines how preschoolers' behavior help predict severity, diagnosis of ADHD at age six

Don't rely on one source of information about your preschoolers' inattention or hyperactivity. Rather, consider how your child behaves at home as well as information from his or her teacher and a clinician. This advice comes from Sarah O'Neill, of The City College of New York, based on research she conducted at Queens College, in an article published in Springer's Journal of Abnormal Child Psychology. [More]
Maternal smoking during pregnancy associated with twofold increased risk of BD in offspring

Maternal smoking during pregnancy associated with twofold increased risk of BD in offspring

A study published today in the American Journal of Psychiatry suggests an association between smoking during pregnancy and increased risk for developing bipolar disorder in adult children. [More]

Study finds increase in use of stimulant medications to treat children and teens with ADHD

Use of stimulant medications to treat Attention-Deficit/Hyperactivity Disorder in children and adolescents has increased significantly over the past several years. [More]
Dopamine improves deficiencies in social behavior, could have implications for neuropsychiatric disorders

Dopamine improves deficiencies in social behavior, could have implications for neuropsychiatric disorders

A stressful pregnancy might be the last thing a future mother needs, but it is to her unborn baby that this stress spells real trouble. All because stress hormones (called glucocorticoids or GCs) can disturb normal foetal brain development, leading to behavioural and/or emotional problems later in life. [More]
Increased mortality in schizophrenia ‘not attributable to drug therapy’

Increased mortality in schizophrenia ‘not attributable to drug therapy’

The increased mortality risk observed among patients with severe psychiatric illness, including schizophrenia, does not seem to be attributable to use of psychopharmacologic therapy, study findings indicate. [More]

Fewer children in UK diagnosed with ADHD than in USA

New research suggests that children are far less likely to be diagnosed with Attention deficit hyperactivity disorder in the UK than they are in the USA. However, the same study, led by the University of Exeter Medical School, suggests that autism diagnosis is still rising. [More]
Study reveals adolescents with ADHD may have driving deficits

Study reveals adolescents with ADHD may have driving deficits

A study using a driving simulator suggests that adolescents with attention-deficit/hyperactivity disorder (ADHD) who were distracted while driving demonstrated more variability in speed and lane position than adolescents without ADHD, according to a study published by JAMA Pediatrics, a JAMA Network publication. [More]
Breastfed children less likely to develop ADHD later in life

Breastfed children less likely to develop ADHD later in life

​We know that breastfeeding has a positive impact on child development and health -including protection against illness. Now researchers from Tel Aviv University have shown that breastfeeding could also help protect against Attention Deficit/Hyperactivity Disorder (ADHD), the most commonly diagnosed neurobehavioral disorder in children and adolescents. [More]
Single dose of methylphenidate can reduce risk of falls among elderly adults

Single dose of methylphenidate can reduce risk of falls among elderly adults

Ben-Gurion University of the Negev researchers have discovered that a single dose of methylphenidate, used to treat Attention Deficit Hyperactivity Disorder and narcolepsy, helps to improve balance control during walking, hence reducing the risk of falls among elderly adults. [More]

Children with SPD have quantifiable differences in brain structure, reveals study

In a groundbreaking new study from UC San Francisco, researchers have found that children affected with sensory processing disorders (SPD) have quantifiable differences in brain structure, showing a biological basis for the disease that sets it apart from other neurodevelopmental disorders. [More]
Researchers identify structural anomalies that may increase risk of ADHD in premature newborns

Researchers identify structural anomalies that may increase risk of ADHD in premature newborns

In the first study of its kind, Natasha Leporé, PhD, and colleagues have pinpointed structural anomalies in the developing brain that may increase the risk of cognitive disabilities, such as frontal executive dysfunction and attention deficit hyperactivity disorder, in premature newborns. [More]
Ritalin helps improve brain function in cocaine addiction

Ritalin helps improve brain function in cocaine addiction

A single dose of a commonly-prescribed attention deficit hyperactivity disorder drug helps improve brain function in cocaine addiction, according to an imaging study conducted by researchers from the Icahn School of Medicine at Mount Sinai. [More]
Prader-Willi syndrome results in dysregulation of circadian and metabolic genes

Prader-Willi syndrome results in dysregulation of circadian and metabolic genes

Researchers with the UC Davis MIND Institute and Agilent Laboratories have found that Prader-Willi syndrome - a genetic disorder best known for causing an insatiable appetite that can lead to morbid obesity - is associated with the loss of non-coding RNAs, resulting in the dysregulation of circadian and metabolic genes, accelerated energy expenditure and metabolic differences during sleep. [More]

Study: Despite struggles with poverty, more children getting health insurance

Families in the United States are making gains in education and health, two key factors in their overall well-being, a report released on Monday showed, adding to data that suggests the U.S. economy is slowly rebounding from the 2007-2009 recession. Still, the latest findings on the state of U.S. children and their parents by the Annie E. Casey Foundation found many families continue to struggle ... Most states also saw more children with health insurance, improvements in birth weights, and fewer youth deaths between 2005 and 2011, it said (Heavey, 6/24). [More]
Researchers examine effect of ADHD in children recovering from mild traumatic brain injury

Researchers examine effect of ADHD in children recovering from mild traumatic brain injury

Researchers at Children's Hospital of Pittsburgh, the University of Pittsburgh, and the University of Chicago have found that children with attention deficit hyperactivity disorder are more likely to demonstrate a moderate disability after sustaining a mild traumatic brain injury than children without ADHD. [More]

Highland Therapeutics subsidiary reports positive HLD-200 Phase-1 results in ADHD patients

Highland Therapeutics, Inc., a specialty pharmaceutical company based in the MaRS Discovery District in Toronto, today announced that its wholly owned subsidiary has generated positive Phase-1 results for HLD-200 - a novel formulation of methylphenidate being developed to treat the symptoms associated with Attention-Deficit/Hyperactivity Disorder. [More]

NeuroSigma's Monarch eTNS System to make Canadian debut at 30th International Epilepsy Congress

NeuroSigma, Inc., a Los Angeles based medical device company, today announced that its Monarch eTNS System for the adjunctive treatment of epilepsy and depression will make its Canadian debut at the 30th International Epilepsy Congress, taking place in Montreal, Canada from June 23 to June 27, 2013. [More]

Children with co-occurrence of autism spectrum disorder and ADHD have greater impairments

In a study of the co-occurrence of attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in early school-age children (four to eight years old), researchers at the Kennedy Krieger Institute found that nearly one-third of children with ASD also have clinically significant ADHD symptoms. [More]

New U-M poll shows 1 in 100 parents believe their kids use prescription stimulants to boost grades

As high schoolers prepare for final exams, teens nationwide may be tempted to use a "study drug" -- a prescription stimulant or amphetamine -- to gain an academic edge. But a new University of Michigan poll shows only one in 100 parents of teens 13-17 years old believes that their teen has used a study drug. [More]

Early-life exposure to traffic-related air pollution associated with higher hyperactivity

Early-life exposure to traffic-related air pollution was significantly associated with higher hyperactivity scores at age 7, according to new research from the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center. [More]